| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. (KRYS) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 120 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.49M | $482.68M | - | |
| Pres | 1.43M | $461.76M | - | |
| Dir | 75.7K | $24.48M | - | |
| VP | 1.0K | $323.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Krishnan Suma | President, R&D | Sell | 50,000 | $177.79 | $8,889,524.59 | -0.3% | -21.3% | +39.4% | |
| Mar 13, 2025 | Krishnan Krish S | President And CEO | Sell | 50,000 | $177.79 | $8,889,524.59 | -0.3% | -21.3% | +39.4% | |
| Feb 27, 2025 | Romano Kathryn | Chief Accounting Officer | Sale+OE | 750 | $175.22 | $131,415.00 | -5.6% | -28.8% | +59.0% | |
| Dec 13, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $164.80 | $8,240,023.05 | -0.2% | +8.4% | +49.5% | |
| Dec 13, 2024 | Krishnan Krish S | President And CEO | Sell | 50,000 | $164.80 | $8,240,023.05 | -0.2% | +8.4% | +49.5% | |
| Sep 12, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $197.77 | $9,888,276.35 | -0.2% | -4.4% | -26.6% | |
| Sep 12, 2024 | Krishnan Krish S | President And CEO | Sell | 50,000 | $197.77 | $9,888,276.35 | -0.2% | -4.4% | -26.6% | |
| Jun 11, 2024 | Krishnan Suma | President, R&D | Sell | 50,000 | $175.76 | $8,788,061.50 | -0.2% | +5.8% | -21.3% | |
| Jun 11, 2024 | Krishnan Krish S | President And CEO | Sell | 50,000 | $175.76 | $8,788,061.50 | -0.2% | +5.8% | -21.3% | |
| May 20, 2024 | Gangolli Julian S | Director | Sale+OE | 20,000 | $164.13 | $3,282,689.72 | -64.4% | +20.8% | -20.0% |